Braunwald E. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction and improved survival. Should the paradigm be expanded? Circulation 1989; 97: 441-444.
Grancer CB, Califf RM, Topol EJ. Thrombolytic therapy for acute myocardial infarction. Drugs 1992; 44: 293-325.
The GUSTO angiografic investigators. The effect of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function, and survival after acute myocardial infarction. N Eng J Med 1993; 329: 1615-22.
Popovic AD, Nescovich NA, Babic R, et al. Independent impact of thrombolytic therapy and vessel patency on left ventricular dilatation. Circulation 1994: 90: 800-807.
Galvani M, Ottani F, Ferrini D, et al. Patency of infarct related artery and left ventricular function as the major determinant of survival after Q wave acute myocardial infarction. Am J Cardiol 1993; 71: 1-7.
Vogt A, Essen RV, Tebbe U, et al. Impact of early perfusion status of the infarct related artery on short-term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of four German multicenter studies. J Am Coll Cardiol 1993; 21: 1391-1395.
Rogers J, Baim DS, Gore JM, et al. Comparison of immediate invasive, delayed invasive and conservative strategies after tissue-type plasminogen activator: Circulation 1990; 81: 1457-1476:
Doevendans PA, Gorgels AP, Zee RV, et al. Electrocardiographic diagnosis of reperfusion during thrombolytic therapy in acute myocardial infarction. Am J Cardiol 1995; 75: 1206-1210.
Shah PK, Cercek B, Lew AS, et al. Angiographic validation of bedside markers of reperfusion. Am Coll Cardiol 1993; 21: 55-61.
Kusniec J, Solodky A, Strasberg B, et al. The relationship between the electrocardiographic pattern with TIMI flow class and ejection fraction in patients with a fırst acute anterior wall myocardial infarction. Eur Heart J 1997; 18: 420-425.
Essen RV, Marx W, Effort S. Spontaneous course of ST segment elevation in acute myocardial infarction. Circulation 1979; 59: 105-112.
Antman EM. Braunwald E. Acute myocardial infarction. Heart Disease A Textbook of Cardiovascular Medicine'de Ed. Braunwald E. Philadelphia WB Saunders, 1997; 1184-1288.
Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in myocardial infarction (TIMI) trial, phase I. A comparison between intravenous tissue plasminogen activator and streptokinase. Circulation 1987; 76: 142-154.
Matetzky S, Barabash G, Shahar A, et al. Early T wave inversion after thrombolytic therapy predicts better coronary perfusion: Clinical and angiographic study. J Am Coll Cardiol 1994; 24: 378-84.
Özmen F, Kabukçu M, Aytemir K, ve ark. Trombolitik tedaviyi takiben perfüzyon durumunu değerlendirmede elektrokardiyogramda ST segment yüksekliğindeki değişikliklerin değeri. MN Kardiyoloji 1996; 3: 306-312.
Pilote L, Miller DP, Califf RM, et al. Determinants of the use of coronary angiography revascularization after thrombolysis for acute myocardial infarction. N Eng J Med 1996; 335: 1198-1205.
Tzivoni D, Chenzbraun A. The significance of ST abnormalities in myocardial infarction. Cardiol Clin 1987; 5: 419-426.
Özmen F, Kabukçu M, Aytemir K, ve ark. Başarılı trombolitik tedavinin bölgesel ve genel sol ventrikül fonksiyonlarına etkisi. Türk Girişimsel Kardiyol Derg 1997; 1: 60-66.
Maeda S, Kubakı K, et al. Pathologic implications of restored positive T waves and persistent negative T waves Q wave myocardial infarction J Am Coll Cardiol 1996; 28: 1514-1518.